Please login to the form below

Not currently logged in
Email:
Password:

Bedrock Group bolsters team with three key appointments

Andy Jobson, Deborah Blain and Vicky O'Connor join company

Bedrock Healthcare Communications has announced the addition of three new members to its team.

Bedrock Group has appointed Andy Jobson as strategic solutions director. Jobson has a background in Molecular Andy JobsonPharmacology, and began his career in medical education in 2009.

In addition to his new role at Bedrock, he works as principal advisor, scientific and business strategy at MYELOMA360. Prior to these roles, Jobson (pictured right) served as director of medical strategy at Spirit Medical Communications Group.

“We are delighted to have Andy on board,” says Alison Cantle, managing director. “Andy’s wide experience in developing and implementing medical education programmes is invaluable to us and our clients. We welcome his grounded approach and innovative thinking.”

Deborah BlainAlso joining Bedrock is Deborah Blain (pictured left), who has been appointed as an account manager following a stint at Lucid Group. Prior to Lucid, Blain worked for ten years at Darwin Healthcare Communications.

Rounding out the new hires is Vicky O’Connor (pictured below, right), who joins Origins Insights – a Bedrock Group company – as strategic solutions director.

She has over 20 years of experience working in Vicky O'Connor market access, public relations and medical communications.

“As Origins Insights grows, our expert team of qualitative researchers and strategists grows. Vicky brings to Origins Insights the ability to apply our unique methodology to a widening range of customers across the drug development lifecycle,” said Jeremy Sayers, managing director of Origins Insights.

Article by
Lucy Parsons

27th February 2020

From: Marketing

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics